Here's what we'll cover Mounjaro (tirzepatide) is part of a family of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists , but it sets itself apart as a so-called dual-action GLP-1/GIP (more on that below)
In the tirzepatide lawsuit, the OFA filed a motion arguing the FDA's shortage decision was effectively a new rule that requires a more comprehensive regulatory process
(c) low high-density lipoprotein level less than 40 mg/dL in men and less than 50 mg/dL in women or on drug therapy for low high-density lipoprotein level (fibrates, nicotinic acid)
Reconstitution, storage, and preparation: protecting your timeline For those using compounded GLP-1 formulations rather than pre-filled brand-name injectors, proper handling directly impacts how well and how consistently the medication works
In June 2019, the FDA approved PT-141 under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women
The mean age at baseline was 65 years, and 61% were men